Literature DB >> 18466986

Increased locomotor activity in mice lacking the low-density lipoprotein receptor.

Gregory A Elder1, Andre Ragnauth, Nathan Dorr, Sonia Franciosi, James Schmeidler, Vahram Haroutunian, Joseph D Buxbaum.   

Abstract

While the low-density lipoprotein receptor (LDLR) is best known for its role in regulating serum cholesterol, LDLR is expressed in brain, suggesting that it may play a role in CNS function as well. Here, using mice with a null mutation in LDLR (LDLR-/-), we investigated whether the absence of LDLR affects a series of behavioral functions. We also utilized the fact that plasma cholesterol levels can be regulated in LDLR-/- mice by manipulating dietary cholesterol to investigate whether elevated plasma cholesterol might independently affect behavioral performance. LDLR-/- mice showed no major deficits in general sensory or motor function. However, LDLR-/- mice exhibited increased locomotor activity in an open field test without evidence of altered anxiety in either an open field or a light/dark emergence test. By contrast, modulating dietary cholesterol produced only isolated effects. While both C57BL/6J and LDLR-/- mice fed a high cholesterol diet showed increased anxiety in a light/dark task, and LDLR-/- mice fed a high cholesterol diet exhibited longer target latencies in the probe trial of the Morris water maze, no other findings supported a general effect of cholesterol on anxiety or spatial memory. Collectively these studies suggest that while LDLR-/- mice exhibit no major developmental defects, LDLR nevertheless plays a significant role in modulating locomotor behavior in the adult.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18466986      PMCID: PMC4662864          DOI: 10.1016/j.bbr.2008.03.036

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  32 in total

Review 1.  Cellular signalling by lipoprotein receptors.

Authors:  J Herz; M Gotthardt; T E Willnow
Journal:  Curr Opin Lipidol       Date:  2000-04       Impact factor: 4.776

2.  Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment.

Authors:  D C Rogers; E M Fisher; S D Brown; J Peters; A J Hunter; J E Martin
Journal:  Mamm Genome       Date:  1997-10       Impact factor: 2.957

3.  Expression of receptors for native and chemically modified low-density lipoproteins in brain microvessels.

Authors:  M Lucarelli; M Gennarelli; P Cardelli; G Novelli; S Scarpa; B Dallapiccola; R Strom
Journal:  FEBS Lett       Date:  1997-01-13       Impact factor: 4.124

Review 4.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

5.  The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice.

Authors:  John D Fryer; Ronald B Demattos; Lynn M McCormick; Mark A O'Dell; Michael L Spinner; Kelly R Bales; Steven M Paul; Patrick M Sullivan; Maia Parsadanian; Guojun Bu; David M Holtzman
Journal:  J Biol Chem       Date:  2005-05-11       Impact factor: 5.157

Review 6.  Genetic modifiers of atherosclerosis in mice.

Authors:  J W Knowles; N Maeda
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-11       Impact factor: 8.311

7.  Inbred strain differences in prepulse inhibition of the mouse startle response.

Authors:  R Paylor; J N Crawley
Journal:  Psychopharmacology (Berl)       Date:  1997-07       Impact factor: 4.530

Review 8.  Low-density lipoprotein receptor--its structure, function, and mutations.

Authors:  Joep C Defesche
Journal:  Semin Vasc Med       Date:  2004-02

Review 9.  Mouse models of atherosclerosis.

Authors:  J L Breslow
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728

10.  A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier.

Authors:  B Dehouck; L Fenart; M P Dehouck; A Pierce; G Torpier; R Cecchelli
Journal:  J Cell Biol       Date:  1997-08-25       Impact factor: 10.539

View more
  15 in total

1.  Spontaneous activity, economy of activity, and resistance to diet-induced obesity in rats bred for high intrinsic aerobic capacity.

Authors:  Colleen M Novak; Carlos Escande; Paul R Burghardt; Minzhi Zhang; Maria Teresa Barbosa; Eduardo N Chini; Steven L Britton; Lauren G Koch; Huda Akil; James A Levine
Journal:  Horm Behav       Date:  2010-03-27       Impact factor: 3.587

Review 2.  ECM receptors in neuronal structure, synaptic plasticity, and behavior.

Authors:  Meghan E Kerrisk; Lorenzo A Cingolani; Anthony J Koleske
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

Review 3.  Mouse models to study the effect of cardiovascular risk factors on brain structure and cognition.

Authors:  Diewertje I Bink; Katja Ritz; Eleonora Aronica; Louise van der Weerd; Mat J A P Daemen
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-21       Impact factor: 6.200

4.  What are lipoproteins doing in the brain?

Authors:  Hong Wang; Robert H Eckel
Journal:  Trends Endocrinol Metab       Date:  2013-11-02       Impact factor: 12.015

5.  Novel cerebrovascular pathology in mice fed a high cholesterol diet.

Authors:  Sonia Franciosi; Miguel A Gama Sosa; Daniel F English; Elizabeth Oler; Twethida Oung; William Gm Janssen; Rita De Gasperi; James Schmeidler; Dara L Dickstein; Christoph Schmitz; Sam Gandy; Patrick R Hof; Joseph D Buxbaum; Gregory A Elder
Journal:  Mol Neurodegener       Date:  2009-10-24       Impact factor: 14.195

Review 6.  How Does p73 Cause Neuronal Defects?

Authors:  Maria Victoria Niklison-Chirou; Richard Killick; Richard A Knight; Pierluigi Nicotera; Gerry Melino; Massimiliano Agostini
Journal:  Mol Neurobiol       Date:  2015-08-13       Impact factor: 5.590

7.  Haploinsufficiency of Cyfip1 produces fragile X-like phenotypes in mice.

Authors:  Ozlem Bozdagi; Takeshi Sakurai; Nathan Dorr; Marion Pilorge; Nagahide Takahashi; Joseph D Buxbaum
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

8.  Increased expression of receptor phosphotyrosine phosphatase-β/ζ is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypes.

Authors:  N Takahashi; T Sakurai; O Bozdagi-Gunal; N P Dorr; J Moy; L Krug; M Gama-Sosa; G A Elder; R J Koch; R H Walker; P R Hof; K L Davis; J D Buxbaum
Journal:  Transl Psychiatry       Date:  2011-05-10       Impact factor: 6.222

9.  Deficiency of Lipoprotein Lipase in Neurons Decreases AMPA Receptor Phosphorylation and Leads to Neurobehavioral Abnormalities in Mice.

Authors:  Tian Yu; Matthew D Taussig; Nicholas V DiPatrizio; Giuseppe Astarita; Daniele Piomelli; Bryan C Bergman; Mark L Dell'Acqua; Robert H Eckel; Hong Wang
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

10.  mTOR drives cerebral blood flow and memory deficits in LDLR-/- mice modeling atherosclerosis and vascular cognitive impairment.

Authors:  Jordan B Jahrling; Ai-Ling Lin; Nicholas DeRosa; Stacy A Hussong; Candice E Van Skike; Milena Girotti; Martin Javors; Qingwei Zhao; Leigh Ann Maslin; Reto Asmis; Veronica Galvan
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-17       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.